Lataa...
The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
The overall efficacy of neoadjuvant chemoradiotherapy (NACT) for locally advanced gastric cancer (LAGC) has been recognized. However, the response rate of NACT is limited due to tumor heterogeneity. For patients who are resistant to NACT, not only the operation timing will be postponed, patients wil...
Tallennettuna:
| Julkaisussa: | Front Oncol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8085495/ https://ncbi.nlm.nih.gov/pubmed/33937042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.641304 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|